No.: HY-182059GSTP1-IN-1 is a selective GSTP1 inhibitor with an IC of 0.79 M and a 50 K of 0.63 M
This age-linked decline corresponds to decreased immunologic function and the onset of disease.10 Epitalon may help counteract your natural interleukin-2 decline by activating interleukin-2 mRNA synthesis, as explained by the researchers behind a 2002 in vitro study on mouse cells
Biohacker Protocol (experimental) Dose: 2 5 mg (= 2050 clicks) Duration: 4 6 weeks Frequency: 5 days per week Cycle Interval: 2 3 months off before repeating Goal / Description: Microdose continuous approach in experimental aging models
Xu, W.-M., He, J., Yu, M.-Q
Cell and tissue data may be normalized to cell number, protein, DNA, or tissue weight, while extracellular-medium measurements should account for culture volume, cell number, incubation time, and viability
De Bock K, Georgiadou M, Schoors S, Kuchnio A, Wong BW, Cantelmo AR, Quaegebeur A, Ghesquiere B, Cauwenberghs S, Eelen G, Phng LK, Betz I, Tembuyser B, Brepoels K, Welti J, Geudens I, Segura I, Cruys B, Bifari F, Decimo I, Blanco R, Wyns S, Vangindertael J, Rocha S, Collins RT, Munck S, Daelemans D, Imamura H, Devlieger R, Rider M, Van Veldhoven PP, Schuit F, Bartrons R, Hofkens J, Fraisl P, Telang S, Deberardinis RJ, Schoonjans L, Vinckier S, Chesney J, Gerhardt H, Dewerchin M, Carmeliet P (2013) Role of PFKFB3-driven glycolysis in vessel sprouting